Daily Roundup

Wednesday, 8th April 2026
Last updated: 18:00 | Max Version 🚀

PME.ASX DRO.ASX LDX.ASX PDI.ASX CGS.ASX

Robust Demand Drives Cogstate's Strong Quarterly Performance

Cogstate Ltd (ASX:CGS), a global leader in clinical trial endpoint data quality and digital cognitive assessments, has reported a stellar performance in the third quarter of fiscal year 2026 (3Q26). The company executed sales contracts totaling $25.4 million during the quarter, bringing the total value of contracts executed over the first nine months of the year to $67.1 million.

This strong demand has translated into a significant increase in Cogstate's contracted revenue. For the second half of fiscal year 2026 (2H26), including revenue recognized during 3Q26, the company has $29.1 million in contracted revenue, up from $21.7 million at the end of December 2025. This has pushed the company's full-year fiscal 2026 (FY26) revenue under contract to $56.0 million, up from the $53.1 million in total revenue recorded in fiscal 2025.

Looking ahead, Cogstate has also seen a substantial increase in contracted revenue for the next financial year, FY27, which now stands at $35.6 million, up from $27.0 million at the end of December 2025.

Pro Medicus Secures Landmark Cloud-Based Imaging Contract with University of Maryland

Pro Medicus Limited (ASX:PME), a leading provider of medical imaging software and services, has announced a significant 5-year, A$23 million contract with the University of Maryland Medical System (UMMS). Under the agreement, Pro Medicus' wholly-owned U.S. subsidiary, Visage Imaging, Inc., will implement its cloud-based Visage 7 Enterprise Imaging Platform, including the Visage 7 Viewer and Visage 7 Workflow, across UMMS.

The implementation of the Visage 7 platform is expected to provide UMMS with a single, unified enterprise imaging platform for diagnostic interpretation, maximizing radiologist efficiency and subspecialty workflows. Pro Medicus CEO Dr. Sam Hupert highlighted that the global shortage of radiologists is driving healthcare institutions to adopt enterprise imaging platforms that leverage the security and scalability of the cloud, which Visage 7 will deliver for UMMS.

DroneShield Announces Leadership Transitions and Strong Quarterly Performance

In other news, DroneShield Limited (ASX:DRO) has announced a leadership transition, with Oleg Vornik stepping down as Managing Director and CEO after more than 10 years in the role. Angus Bean, the company's Chief Product Officer, has been appointed as the new Managing Director and CEO, effective immediately.

The company also reported a strong performance in the first quarter of fiscal year 2026 (1Q26), with record quarterly cash receipts of $77 million, up 361% year-over-year. This comes on the back of DroneShield's impressive financial results in fiscal 2025, where the company reported $216.5 million in revenues, a 276% increase from the previous year, and $33.3 million in Underlying Profit before Tax.

Predictive Discovery and Robex Resources Merge to Create a Leading West African Gold Company

Lastly, Predictive Discovery Limited (ASX:PDI) and Robex Resources Inc. (Robex) have announced that their proposed merger has been declared unconditional and is proceeding to implementation. The combined entity will create a leading West African gold company with a strengthened portfolio of high-quality assets, targeting production of more than 400,000 ounces of gold per annum by 2029.

The merger brings together a world-class mine-building and operations team with the tier-one Bankan Project, as well as financing synergies and balance sheet strength to support the development of the Bankan Project without the need for additional equity or project finance debt. The combined group is well-positioned to advance its development priorities and deliver disciplined, sustainable growth.